Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-27T20:59:24.906Z Has data issue: false hasContentIssue false
  • English
  • Français

Review of a Randomized-Controlled Trial of Adjunctive Bupropion in the Treatment of SSRI-Induced Sexual Dysfunction

Published online by Cambridge University Press:  20 September 2006

Anna Lembke  and
Charles DeBattista
Anna Lembke
Affiliation:
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
Charles DeBattista
Affiliation:
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

bupropionsexualside-effectsserotoninantidotedysfunction.
Type
Review Article
Information
Progress in Neurotherapeutics and Neuropsychopharmacology , Volume 2 , Issue 1 , March 2007 , pp. 187 - 192
Copyright
© 2007 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ashton, A.K. & Rosen, R.C. (1998). Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. Journal of Clinical Psychiatry, 59, 112–115.CrossRefGoogle Scholar
Balon, R. (1993). Fluoxetine-induced sexual dysfunction and yohimbine. Journal of Clinical Psychiatry, 54, 161–162.Google Scholar
Balon, R. (1996). Intermittent amantadine for fluoxetine-induced anorgasmia. Journal of Sex and Marital Therapy, 22, 290–292.CrossRefGoogle Scholar
Bartlik, B.D., Kaplan, P & Kaplan, H.S. (1995). Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. Journal of Sex and Marital Therapy, 21, 264–271.CrossRefGoogle Scholar
Beck, A.T., et al. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.CrossRefGoogle Scholar
Clayton, A.H., et al. (2004). A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. Journal of Clinical Psychiatry, 65, 62–67.CrossRefGoogle Scholar
Gitlin, M.J. (1994). Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. Journal of Clinical Psychiatry, 55, 406–413.Google Scholar
Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology, E. US Department of Health, and Welfare Publications (ADM), Editor. National Institute of Mental Health: Rockville, Maryland. pp. 218–222.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry, 23, 56–62.CrossRefGoogle Scholar
Harvey, K.V. & Balon, R. (1995). Clinical implications of antidepressant drug effects on sexual function. Annal Clinical Psychiatry, 7, 189–201.CrossRefGoogle Scholar
Jespersen, S., et al. (2004). A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology, 19, 161–164.CrossRefGoogle Scholar
Labbate, L.A. & Pollack, M.H. (1994). Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Annal Clinical Psychiatry, 6, 13–15.CrossRefGoogle Scholar
Labbate, L.A., et al. (1997). Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Annal Clinical Psychiatry, 9, 241–245.CrossRefGoogle Scholar
Landen, M., et al. (1999). Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. Journal Clinical Psychopharmacology, 19, 268–271.CrossRefGoogle Scholar
Lane, R.M. (1997). A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management. Journal of Psychopharmacology, 11, 72–82.CrossRefGoogle Scholar
Masand, P.S., et al. (2001). Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. American Journal of Psychiatry, 158, 805–807.CrossRefGoogle Scholar
McGahuey, C.A., et al. (2000). The Arizona Sexual Experience Scale (ASEX): reliability and validity. Journal Sex and Marital Therapy, 26, 25–40.Google Scholar
Michelson, D., et al. (2000). Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. American Journal of Psychiatry, 157, 239–243.CrossRefGoogle Scholar
Nelson, J.C., Portera, L. & Leon, A.C. (2005). Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine. Journal Clinical Psychiatry, 66, 1409–1414.CrossRefGoogle Scholar
Perlis, R.H., et al. (2002). Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice. Harvard Review of Psychiatry, 10, 109–114.CrossRefGoogle Scholar
Rosenberg, K.P. (1999). Sildenafil citrate for SSRI-induced sexual side effects. American Journal of Psychiatry, 156, 157.Google Scholar
Schaller, J.L. & Behar, D. (1999). Sildenafil citrate for SSRI-induced sexual side effects. American Journal of Psychiatry, 156, 156–157.CrossRefGoogle Scholar
Taylor, J., Rosen, R.C. & Leiblum, S. (1994). Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Archives of Sexual Behavior, 23, 627–643.CrossRefGoogle Scholar